Kyverna Therapeutics (KYTX) Cash & Current Investments (2023 - 2026)
Kyverna Therapeutics' Cash & Current Investments came in at $199.43 million for Q2 2026, down 5.8% from $211.68 million a year earlier and down 15.7% from the prior quarter.
Powered by 
Analysis
Kyverna Therapeutics (KYTX) Cash & Current Investments (2023 - 2026) Analysis & Trends
At the end of FY2025, Kyverna Therapeutics' Cash & Current Investments was $279.29 million, down 2.3% from FY2024.
- Going back by year, Cash & Current Investments was $285.98 million in FY2024 (+397.0%) and $57.54 million in FY2023.
- The five-year range for quarterly Cash & Current Investments is $22.97 million (Q3 2023) to $369.79 million (Q1 2024).
- Year-over-year, Cash & Current Investments has declined for six consecutive quarters, with growth averaging 38.0% over the last seven quarters.
- The fastest year-over-year change in Cash & Current Investments over five years came in Q1 2024 (growth of 829.5%), and the weakest in Q3 2025 (a decline of 46.8%).
- Business Quant data shows KYTX's Cash & Current Investments at $236.49 million (Q1 2026), $279.29 million (Q4 2025) and $171.16 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Kyverna Therapeutics | 331.86 Mn | -554.51 Mn | - | 199.43 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 199.43 Mn |
| Mar 31, 2026 | 236.49 Mn |
| Dec 31, 2025 | 279.29 Mn |
| Sep 30, 2025 | 171.16 Mn |
| Jun 30, 2025 | 211.68 Mn |
| Mar 31, 2025 | 242.67 Mn |
| Dec 31, 2024 | 285.98 Mn |
| Sep 30, 2024 | 321.59 Mn |
| Jun 30, 2024 | 346.24 Mn |
| Mar 31, 2024 | 369.79 Mn |
| Dec 31, 2023 | 57.54 Mn |
| Sep 30, 2023 | 22.97 Mn |
| Jun 30, 2023 | 53.43 Mn |
| Mar 31, 2023 | 39.79 Mn |
API Access
Kyverna Therapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=KYTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "KYTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=KYTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();